Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02773407Phase 3Completed
A Phase 3 trial of trimethoprim + sulfamethoxazole in Undifferentiated febrile illness (AUFI), sponsored by Oxford University Clinical Research Unit. Started May 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02773407.